rs8007267 — GCH1

Promoter variant affecting GTP cyclohydrolase 1 expression and pain sensitivity, with opposite effects in European vs African populations

See your personal result for GCH1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Pain-Protective Haplotype That Isn't Always Protective

GTP cyclohydrolase 1 (GCH1) is the rate-limiting enzyme in the synthesis of tetrahydrobiopterin (BH4)11 tetrahydrobiopterin (BH4)
A critical cofactor for producing dopamine, serotonin, norepinephrine, and nitric oxide, and rs8007267 sits in the promoter region controlling its expression. This variant is one of three SNPs defining a haplotype with profound effects on pain sensitivity22 pain sensitivity
The pain-protective haplotype reduces BH4 production in response to inflammation and nerve injury, but here's the twist: whether it increases or decreases your pain depends on your ancestry.

The Mechanism

Rs8007267 lies in the 5' untranslated region (promoter) of GCH1, where it influences gene transcription. After nerve injury or inflammation, GCH1 normally ramps up production dramatically, flooding sensory neurons with BH433 sensory neurons with BH4
BH4 levels increase in dorsal root ganglia after nerve injury. High BH4 drives excess nitric oxide production and neurotransmitter signaling, amplifying pain hypersensitivity. The variant forms of this promoter region blunt that upregulation — less GCH1 induction means less BH4 surge.

The critical detail: rs8007267 functions as part of a three-SNP haplotype (CAT: rs10483639-C, rs3783641-A, rs8007267-T). Carriers of this haplotype show reduced GCH1 mRNA upregulation44 reduced GCH1 mRNA upregulation
Immortalized leukocytes from haplotype carriers showed decreased GCH1 induction after forskolin stimulation compared to controls when stimulated, maintaining lower BH4 levels even under inflammatory conditions.

The Evidence — and the Population Paradox

In the landmark 2006 study by Tegeder et al.55 landmark 2006 study by Tegeder et al.
168 patients undergoing lumbar diskectomy for radicular back pain, carriers of the T allele at rs8007267 (part of the CAT haplotype) reported significantly less postoperative pain. The haplotype frequency was 15.4% in Europeans. Healthy homozygous carriers exhibited reduced experimental pain sensitivity — higher pain thresholds to mechanical stimuli.

But in 2014, Belfer et al. discovered the opposite effect in African Americans with sickle cell disease66 Belfer et al. discovered the opposite effect in African Americans with sickle cell disease
n=228 discovery cohort, n=513 replication cohort. The T allele was associated with MORE frequent pain crises (OR 2.23, p=0.004) and higher in vitro BH4 production. The same allele, different haplotype backgrounds, opposite outcomes.

Practical Implications

For most people of European descent, the T allele may offer modest protection against chronic pain after injury or surgery. The effect is real but not absolute — you won't be immune to pain, but you may experience less severe or prolonged pain states. For people of African descent, especially those with conditions involving recurrent inflammatory pain (like sickle cell disease), the T allele may be a vulnerability factor.

The BH4 pathway is a therapeutic target. The existence of healthy individuals homozygous for the low-BH4 haplotype suggests substantial BH4 reduction can be tolerated. No drugs targeting this pathway are clinically available yet, but they're in development.

Interactions

Rs8007267 forms a tight haplotype block with rs3783641 (intron 1) and rs10483639 (3' UTR)77 haplotype block with rs3783641 (intron 1) and rs10483639 (3' UTR)
These three SNPs capture the pain-protective haplotype with 100% sensitivity and specificity. The haplotype effect is stronger than any single SNP alone. Testing all three SNPs provides the most accurate assessment of your GCH1 pain sensitivity phenotype. This would be an ideal candidate for a compound implication: individuals carrying the complete CAT haplotype (CC at rs10483639, AA at rs3783641, TT at rs8007267) have the most pronounced pain-protective effect in European populations, with approximately 2% being homozygous "double cats".

There may also be interactions with other pain-related genes (COMT, OPRM1) though evidence is limited. One study found no association between GCH1 haplotype and chronic widespread pain88 no association between GCH1 haplotype and chronic widespread pain
When tested in fibromyalgia-like conditions, the haplotype showed no effect, suggesting context-specific effects — protective for injury/inflammation-induced pain but not for centralized pain syndromes.

Genotype Interpretations

What each possible genotype means for this variant.

CC High BH4 Responder Normal

Standard GCH1 response to pain and inflammation

You have two copies of the common C allele at this GCH1 promoter position. In European populations, this is the most common genotype (about 65% of people). Your GCH1 enzyme responds normally to inflammatory signals, ramping up BH4 production when needed for injury repair and immune responses. This is the ancestral, fully functional state — neither protective nor risk-conferring for most pain conditions.

CT Intermediate Pain Sensitivity Intermediate

One copy of ancestry-dependent variant affecting pain response

You carry one copy of the T variant. The functional impact depends critically on your genetic ancestry. In people of primarily European descent, this genotype is present in about 30% and may offer modest protection against developing chronic pain after nerve injury or surgery. In people of African descent, this genotype is part of a different haplotype background and has neutral to slightly increased pain sensitivity. The effect is dose-dependent — one copy has intermediate effects compared to zero or two copies.

TT Ancestry-Dependent Pain Variant Intermediate

Two copies of variant with opposite effects in different populations

You have two copies of the T allele. This genotype is relatively uncommon in Europeans (about 5%) but much more common in African populations (about 10-15%). The functional consequence is ancestry-specific. In European populations, TT is part of the "pain-protective" haplotype associated with lower pain ratings after surgery, faster recovery from injury-induced pain, and reduced experimental pain sensitivity. In African populations, TT is associated with INCREASED pain frequency in sickle cell disease and higher BH4 production. The mechanistic difference likely reflects distinct haplotype blocks in different ancestral backgrounds — the same SNP, different functional contexts.